Annual SG&A:
$0.00-$63.29M(-100.00%)Summary
- As of today, ADMA annual SG&A is $0.00, with the most recent change of -$63.29 million (-100.00%) on December 31, 2024.
- During the last 3 years, ADMA annual SG&A has fallen by -$55.19 million (-100.00%).
- ADMA annual SG&A is now -100.00% below its all-time high of $70.30 million, reached on December 31, 2022.
Performance
ADMA SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$23.37M(-100.00%)Summary
- As of today, ADMA quarterly SG&A is $0.00, with the most recent change of -$23.37 million (-100.00%) on September 30, 2025.
- Over the past year, ADMA quarterly SG&A has dropped by -$19.58 million (-100.00%).
- ADMA quarterly SG&A is now -100.00% below its all-time high of $25.36 million, reached on March 31, 2025.
Performance
ADMA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$1.05B+$209.45M(+16.65%)Summary
- As of today, ADMA TTM SG&A is -$1.05 billion, with the most recent change of +$209.45 million (+16.65%) on September 30, 2025.
- Over the past year, ADMA TTM SG&A has dropped by -$1.12 billion (-1598.32%).
- ADMA TTM SG&A is now -923098.94% below its all-time high of -$113.60 thousand.
Performance
ADMA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
ADMA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -100.0% | -100.0% | -1598.3% |
| 3Y3 Years | -100.0% | -100.0% | -1662.7% |
| 5Y5 Years | -100.0% | -100.0% | -3064.3% |
ADMA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -100.0% | at low | -100.0% | at low | at high | +46.9% |
| 5Y | 5-Year | -100.0% | at low | -100.0% | at low | at high | +46.9% |
| All-Time | All-Time | -100.0% | at low | -100.0% | at low | >-9999.0% | +46.9% |
ADMA Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $0.00(-100.0%) | $73.33M(-21.1%) |
| Jun 2025 | - | $23.37M(-7.9%) | $92.91M(+6.7%) |
| Mar 2025 | - | $25.36M(+3.1%) | $87.09M(+11.1%) |
| Dec 2024 | $0.00(-100.0%) | $24.59M(+25.6%) | $78.37M(+12.0%) |
| Sep 2024 | - | $19.58M(+11.6%) | $70.00M(+6.7%) |
| Jun 2024 | - | $17.55M(+5.4%) | $65.61M(+3.1%) |
| Mar 2024 | - | $16.64M(+2.6%) | $63.64M(+0.6%) |
| Dec 2023 | $63.29M(-10.0%) | $16.22M(+6.8%) | $63.29M(-4.2%) |
| Sep 2023 | - | $15.19M(-2.5%) | $66.05M(-3.7%) |
| Jun 2023 | - | $15.58M(-4.4%) | $68.61M(-0.5%) |
| Mar 2023 | - | $16.29M(-14.2%) | $68.92M(-2.0%) |
| Dec 2022 | $70.30M(+27.4%) | $18.98M(+6.9%) | $70.30M(+4.7%) |
| Sep 2022 | - | $17.75M(+11.7%) | $67.11M(+6.1%) |
| Jun 2022 | - | $15.89M(-10.1%) | $63.23M(+4.4%) |
| Mar 2022 | - | $17.67M(+11.9%) | $60.58M(+9.8%) |
| Dec 2021 | $55.19M(+40.7%) | $15.79M(+13.9%) | $55.19M(+13.3%) |
| Sep 2021 | - | $13.87M(+4.8%) | $48.69M(+7.8%) |
| Jun 2021 | - | $13.24M(+7.9%) | $45.15M(+8.8%) |
| Mar 2021 | - | $12.28M(+32.0%) | $41.49M(+10.2%) |
| Dec 2020 | $39.22M(+39.7%) | $9.30M(-10.0%) | $37.65M(+6.4%) |
| Sep 2020 | - | $10.33M(+7.9%) | $35.38M(+8.2%) |
| Jun 2020 | - | $9.58M(+13.6%) | $32.70M(+9.7%) |
| Mar 2020 | - | $8.43M(+19.9%) | $29.80M(+7.9%) |
| Dec 2019 | $28.08M(-7.4%) | $7.03M(-8.1%) | $27.62M(-7.9%) |
| Sep 2019 | - | $7.65M(+14.6%) | $29.98M(+1.1%) |
| Jun 2019 | - | $6.68M(+6.9%) | $29.66M(+6.0%) |
| Mar 2019 | - | $6.25M(-33.5%) | $27.98M(+4.7%) |
| Dec 2018 | $30.31M(+67.5%) | $9.40M(+28.2%) | $26.74M(+18.7%) |
| Sep 2018 | - | $7.33M(+46.4%) | $22.53M(+16.2%) |
| Jun 2018 | - | $5.01M(+0.0%) | $19.39M(+3.0%) |
| Mar 2018 | - | $5.00M(-3.5%) | $18.82M(+4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $18.09M(+113.0%) | $5.18M(+23.6%) | $18.09M(+11.7%) |
| Sep 2017 | - | $4.20M(-5.4%) | $16.19M(+17.5%) |
| Jun 2017 | - | $4.44M(+3.7%) | $13.78M(+24.5%) |
| Mar 2017 | - | $4.28M(+30.3%) | $11.06M(+30.2%) |
| Dec 2016 | $8.49M(+25.9%) | $3.28M(+84.6%) | $8.49M(+19.7%) |
| Sep 2016 | - | $1.78M(+3.2%) | $7.10M(-4.0%) |
| Jun 2016 | - | $1.72M(+1.0%) | $7.39M(+4.0%) |
| Mar 2016 | - | $1.71M(-9.4%) | $7.11M(+5.4%) |
| Dec 2015 | $6.75M(+39.8%) | $1.88M(-9.3%) | $6.75M(+12.9%) |
| Sep 2015 | - | $2.08M(+44.6%) | $5.97M(+21.2%) |
| Jun 2015 | - | $1.44M(+6.8%) | $4.93M(-2.1%) |
| Mar 2015 | - | $1.35M(+21.0%) | $5.04M(+4.4%) |
| Dec 2014 | $4.82M(+10.5%) | $1.11M(+7.4%) | $4.82M(+2.4%) |
| Sep 2014 | - | $1.04M(-32.9%) | $4.71M(-9.0%) |
| Jun 2014 | - | $1.54M(+35.9%) | $5.18M(-1.7%) |
| Mar 2014 | - | $1.13M(+13.6%) | $5.27M(-13.4%) |
| Dec 2013 | $4.37M(-10.7%) | $998.60K(-33.6%) | $6.08M(-1.9%) |
| Sep 2013 | - | $1.50M(-7.8%) | $6.20M(-0.3%) |
| Jun 2013 | - | $1.63M(-16.2%) | $6.22M(+9.0%) |
| Mar 2013 | - | $1.95M(+74.5%) | $5.70M(+28.7%) |
| Dec 2012 | $4.89M(+241.4%) | $1.12M(-26.8%) | $4.43M(+33.6%) |
| Sep 2012 | - | $1.52M(+36.5%) | $3.31M(+85.1%) |
| Jun 2012 | - | $1.12M(+65.4%) | $1.79M(+165.4%) |
| Mar 2012 | - | $674.60K(>+9900.0%) | $674.60K(+3023.1%) |
| Dec 2011 | $1.43M(+0.4%) | - | - |
| Mar 2011 | - | $3800.00(-2.6%) | $21.60K(-0.9%) |
| Dec 2010 | $1.43M(+6856.1%) | $3900.00(0.0%) | $21.80K(+1.9%) |
| Sep 2010 | - | $3900.00(-61.0%) | $21.40K(+22.3%) |
| Jun 2010 | - | $10.00K(+150.0%) | $17.50K(+133.3%) |
| Jun 2010 | $20.50K | - | - |
| Mar 2010 | - | $4000.00(+14.3%) | $7500.00(+114.3%) |
| Dec 2009 | - | $3500.00 | $3500.00 |
FAQ
- What is ADMA Biologics, Inc. annual SG&A?
- What is the all-time high annual SG&A for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. annual SG&A year-on-year change?
- What is ADMA Biologics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. quarterly SG&A year-on-year change?
- What is ADMA Biologics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. TTM SG&A year-on-year change?
What is ADMA Biologics, Inc. annual SG&A?
The current annual SG&A of ADMA is $0.00
What is the all-time high annual SG&A for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high annual SG&A is $70.30M
What is ADMA Biologics, Inc. annual SG&A year-on-year change?
Over the past year, ADMA annual SG&A has changed by -$63.29M (-100.00%)
What is ADMA Biologics, Inc. quarterly SG&A?
The current quarterly SG&A of ADMA is $0.00
What is the all-time high quarterly SG&A for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high quarterly SG&A is $25.36M
What is ADMA Biologics, Inc. quarterly SG&A year-on-year change?
Over the past year, ADMA quarterly SG&A has changed by -$19.58M (-100.00%)
What is ADMA Biologics, Inc. TTM SG&A?
The current TTM SG&A of ADMA is -$1.05B
What is the all-time high TTM SG&A for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high TTM SG&A is -$113.60K
What is ADMA Biologics, Inc. TTM SG&A year-on-year change?
Over the past year, ADMA TTM SG&A has changed by -$1.12B (-1598.32%)